IDEXX Laboratories, Inc. (IDXX)

Market Cap	33.91B
Revenue (ttm)	3.90B
Net Income (ttm)	887.87M
Shares Out	81.33M
EPS (ttm)	10.67
PE Ratio	39.07
Forward PE	34.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	287,622
Open	422.52
Previous Close	423.60
Day's Range	416.81 - 424.28
52-Week Range	398.50 - 548.88
Beta	1.39
Analysts	Buy
Price Target	533.75 (+28.01%)
Earnings Date	Apr 30, 2025

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 21, 1991
• Employees: 11,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IDXX
• Website: https://www.idexx.com

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Analyst Forecast

According to 8 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $533.75, which is an increase of 28.01% from the latest price.

Price Target

$533.75

(28.01% upside)

Analyst Consensus: Buy